Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bioasis Technologies Inc. V.BTI

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.


TSXV:BTI - Post by User

Comment by JDavenporton Oct 21, 2021 3:16pm
122 Views
Post# 34034140

RE:RE:Protalix & Bioasis. Could they be a match?

RE:RE:Protalix & Bioasis. Could they be a match?prophetoffacts has posted interrelationships between Bioasis, Oxyrane, Pfizer and Shire. Shire did some work with Bioasis that did not go well on Shire's part. Bioasis and xB3 were fine. Pfizer has kept a close watch on Bioasis for years. There could, maybe, have been something there if Bioasis had made serious efforts towards clinical trials in the past. Bioasis is making those efforts now, big time.

I have stated that Protalix might be involved with Bioasis, and if so, Protalix likely can't do Gaucher's disease with Bioasis because it already does that with Pfizer. That may be why Bioasis went to Oxyrane. Oxyrane appears to have a great Gaucher's enzyme and the ability to manufacture an xB3-Oxyrane fusion protein. An d, of course, Bioasis stopped metioning Cerezyme in it literature many montha ago, possibly because to mention it would now be inaccurate, if the Bioasis/Oxyrane deal is all about designing and manufaturing an xB3/Oxyrane Gaucher's drug.

Protalix sold most of its rights to their Gaucher's drug to Pfizer and it wouldn't surprise me if Protalix was required to sign a non-compete agreement Pfizer with respect to Gaucher's.

The relationships are quite close here with all companies having or having had agreements with Bioasis or being aware of Bioasis for quite a long time. 

jd
<< Previous
Bullboard Posts
Next >>